ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Revance Therapeutics Inc

Revance Therapeutics Inc (RVNC)

3.97
0.00
(0.00%)
Closed April 16 4:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.97
Bid
3.95
Ask
3.99
Volume
-
0.00 Day's Range 0.00
3.96 52 Week Range 37.98
Market Cap
Previous Close
3.97
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,774,817
Shares Outstanding
88,214,054
Dividend Yield
-
PE Ratio
-1.08
Earnings Per Share (EPS)
-3.67
Revenue
234.04M
Net Profit
-323.99M

About Revance Therapeutics Inc

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD pl... Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Revance Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RVNC. The last closing price for Revance Therapeutics was $3.97. Over the last year, Revance Therapeutics shares have traded in a share price range of $ 3.96 to $ 37.98.

Revance Therapeutics currently has 88,214,054 shares outstanding. The market capitalization of Revance Therapeutics is $350.21 million. Revance Therapeutics has a price to earnings ratio (PE ratio) of -1.08.

RVNC Latest News

Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting

– Two presentations highlighting data on DAXXIFY® for the treatment of cervical dystonia, including a new analysis from ASPEN trials assessing patient-desired retreatment intervals and one...

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revance Therapeutics, Inc. (NASDAQ: RVNC) today announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units (“RSUs”) to 29 employees. The RSUs vest over four...

Revance Announces Pricing of $100.0 Million Public Offering of Common Stock

Revance Therapeutics, Inc. (Nasdaq: RVNC) (“Revance” or the “Company”) today announced the pricing of an underwritten public offering of 16,000,000 shares of its common stock. The shares of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.52-11.58129175954.494.943.9617891744.31809595CS
4-0.97-19.63562753044.945.423.9614529584.61692356CS
12-2.21-35.76051779946.187.563.9617748175.56560899CS
26-4.72-54.31530494828.699.93.9617299606.58586787CS
52-26.32-86.893364146630.2937.983.96166786213.9859088CS
156-24.5-86.055497014428.4737.983.96120480818.74187504CS
260-10.13-71.843971631214.137.983.9694381919.27324907CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.4174
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.04
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.90
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.2801
(0.00%)
0
AACGATA Creativity Global
$ 0.86
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.4174
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.04
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.90
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.2801
(0.00%)
0
AACGATA Creativity Global
$ 0.86
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.4174
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.04
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.90
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.2801
(0.00%)
0
AACGATA Creativity Global
$ 0.86
(0.00%)
0

RVNC Discussion

View Posts
mrwilson31 mrwilson31 6 hours ago
Wow!!!
👍️0
vinmantoo vinmantoo 10 hours ago
Well, closed under $4/share. Some day RVNC will stop going down. I just hope it is before it gets to zero. 🤣

A little gallows humor.
👍️ 2 😃 1 🥹 1
DewDiligence DewDiligence 12 hours ago
Those are ancillary data on retreatment intervals from the ASPEN-1 and ASPEN–OLS trials. Worth knowing, but not market-moving.
👍️ 2
go seek go seek 12 hours ago
I’m sure the data presented are positive for Daxxi and Revance, but this data won’t move the stock.
👍️0
girlfriend girlfriend 12 hours ago
Is any body expecting positive data on Daxxify from the conference currently taking place: https://ih.advfn.com/stock-market/NASDAQ/revance-therapeutics-RVNC/stock-news/93643006/revance-to-present-new-daxxify-data-at-the-americ
🤡 1
stocksrising stocksrising 12 hours ago
Yes sir, agreed..mainly it’s regarding 3rd Tranche, and if he can share any color( which is doubtful, but never know til you ask) or do we have to wait for Q1 CC…Will update if anything meaningful
👍️0
Emannow Emannow 13 hours ago
Just an example, there is a Med Spa doctor in the Mid Atlantic and she makes $140,000 plus annually published on the Sunshine Act as a speaker for Botox/Juvederm. My guess is the practice also get $40,000 to $60,000 in free staff training products which are sold to patients at full price. This type of bribery goes on all across the USA with dozens of injectors.

This Med Spa doctor will not even see the RVNC rep!!!
👍️ 2 💯 1
stocksrising stocksrising 13 hours ago
Pretty sure this is the same Laurence( his says New Street) that is the contact person, but just him VM and start repore

Investors
Laurence Watts, 619-916-7620
laurence@newstreetir.com
👍️0
edcoolidge edcoolidge 14 hours ago
Some aesthetics practices may genuinely not be offering Daxxify because they were turned off by their interactions with their Revance sales rep or management but that doesn't really pass the smell test. It's clear many unscrupulous CosmeticMDs are being compensated financially by Abbvie/Galderma one way or another to steer their patients towards the legacy toxins and maintain the status quo. In therapeutics payers will have a very strong incentive to switch patients to the best toxin with the best price (Daxxify) and the doctors don't have a conflict of interest that violates their Hippocratic oath.
👍️ 1 🤡 1
DewDiligence DewDiligence 14 hours ago
The new IR firm (#msg-174240308) should be able to answer any question that Jessica could.
👍️ 2
DewDiligence DewDiligence 14 hours ago
RVNC IR is_now_handled_by Gilmartin Group, which has an impressive client list:

https://gilmartinir.com/clients/clients-overview/

The clients are listed in alphabetical order; scan down to see the full list. To see only the biotech clients, click on the “Biotechnology” tab.
👍️ 4
stocksrising stocksrising 14 hours ago
Wow, I was thinking same question if she can share without recourse by HR…after losing Jessica, I lost a good contact that could answer some simple , legal questions ..
👍️0
Emannow Emannow 15 hours ago
I know Foley was 100% involved with ALL the bad decisions and he should be fired like any other CEO who has made terrible decisions. Foley is 100% a hatchet man, and my guess is that is why the Board kept him. Foley has loyalty only to his own paycheck! Foley is there for one reason, to bring the company into profit and sell it!

Sadly, RVNC is 100% a manipulated stock by the shorts...would not be surprised is AbbVie is shorting RVNC....Hopefully, Foley will get the Sxxt out of his mouth and make some type of positive announcement soon to change the course of the SP.
👍️ 2
stocksrising stocksrising 15 hours ago
Ms.D,
Thank You for all the Insightful Information and although you put your employment on the line( ie-if “HR”alerted—not suggesting anything nefarious nor insider trading, whistleblow) I / we appreciate what you’re going thru!!!!
… and as an investor who is also down ~$350k+ (main account), I hope you continue and thrive at Revance..sadly the majority of my ‘circle’ of friends
(Palm Beaches, perhaps the most plastic place on earth other than Bev Hills, etc.) never have heard of Daxxy!! And although my 2 buds own the most successful practice’s here, they offer but seemingly not major supporters of the product ( at first it was the pricing, then duration claims) and now most disturbingly Foley/Management!!! I’m trying to touch base with them again to see if Foley is personally reaching out( especially to the larger of the 2 who boasted about his ‘friendship and respect/admiration) for him but had since waned :(

Curious, in your humble and noticeably informed opinion, is there another internal candidate, or perhaps more probable a person outside who could replace Foley?? Any internal ‘cooler’ discussions that you can share without recourse?
Thanks again and keep the faith, one way or another, many of US believe the company will prosper with or w/out Mark!!!!
GLTA
👍️ 3
PioneerUniverse8 PioneerUniverse8 16 hours ago
I thought you didn't like what Foley was doing to RVNC, like just two posts ago. Anything that happened in the meantime that made you change your mind?
👍️ 1
10nisman 10nisman 17 hours ago
(Commentary: any investor who thinks it’s beyond the pale to admit a previous mistake should probably stick to mutual funds)SMH. Admitting a mistake and marketing the mistake on Instagram are very different things. We have injectors on this board that cannot admit basic math errors and they're posting under aliases.

B) as for patients… your logic makes no sense. There is zero loss of face to admitting you moved practices because a different practice could make Daxxy work, and previous practice couldn’t.What incentive is there for a patient to do this? You want a patient to throw a practice under the bus? The correct play would be for the great injectors (those who didn't get it wrong) to market these patients they helped not the patients themselves.
👍️ 4
iwfal iwfal 18 hours ago
Why would either a patient or injector make a video like that? Makes absolute zero sense. You want an injector to say... I'm an idiot and didn't know what I was doing, but now I do? Or you want a patient to say I went to a really bad injector but then found a new injector who knows what they are doing?

?

A) Injectors: There were, in fact, several Instagram injector posts like that from the early rollout phase. Injectors who noted it didn’t work very well initially, but they figured it out. (Commentary: any investor who thinks it’s beyond the pale to admit a previous mistake should probably stick to mutual funds)

B) as for patients… your logic makes no sense. There is zero loss of face to admitting you moved practices because a different practice could make Daxxy work, and previous practice couldn’t.
👍️0
Emannow Emannow 20 hours ago
The positive side is RVNC will survive and Daxi will be available for both aesthetic and therapeutic patients. Daxi will provide superior outcomes to many patients which the #1 goal in our medical world. The Aesthetic World will see faster onset, longer duration, improved skin tone and better profitability.. The Therapeutic World will see faster onset, longer duration, less side effects from spread to the toxin and lower cost to the patient, provider and payer. These competitive advantages will be the factors and forces which grow Daxi sales.

The Negative side is Foley is and has to bring the "expense element" of RVNC in line with sales revenues. Aesthetic Daxi will continue to gain market share as the aesthetic team builds and converts injectors to Daxi with the benefits of Daxi and the additional profits that Daxi generates for the practice. Aesthetic injectors are all about profits. Therapeutic Daxi will soon be available and selling which will continue to build market presence. Therapeutic doctors are all about providing patients with the best medical product to treat the patient's condition. International Daxi sales will also begin. And there is also the Generic Botox element which is coming soon,

Foley had to and is cutting costs in anyway possible in an effort to match revenues and expenses to create a profitable RVNC. From the communications on this board it appears Foley is doing just that. Share price will recover and begin to go up as soon as investors realize and see how RNVC has been rebuilt. Foley is a hatchet man going into a company that was destine run out of cash and is now rebuilding the infra-structure to match sales and will come out a shining star.
👍️ 2
Ms.Dtox Ms.Dtox 23 hours ago
Well leadership doesn’t communicate. All we have to go by is who is here to support product marketing and launches.

We no longer have a team to support Daxxify aesthetics relaunch efforts, we have no staff to launch therapeutics for CD. Everyone is gone - IR and Comms teams resigned. Media, PR, and investor relations has been outsourced. Not a great indicator.
👍️ 4
Ms.Dtox Ms.Dtox 23 hours ago
I’m referring to previous posts regarding the mall events and Erica posing in front of a wrapped vehicle. Those were not successful events by any stretch. This is just social media marketing.

There are plenty of organic social posts that are real and are favorable from top Derms and injectors.
👍️ 2
Ms.Dtox Ms.Dtox 23 hours ago
Hi. Answering your question about stock grants. I’m referring to vested stock units as part of negotiated signing compensation, vested stock units that were grants (still as negotiated compensation in lieu of annual raises) and employee purchased stock. The first two are earned as part of compensation and in my case I paid $48k for employee purchase stock over a period of 4 years that grew exponentially. We could not sell these during long black out periods. I also have Restricted Stock units that have not vested that aren’t worth much at this point.

I don’t think of this as a freebie or a windfall. It’s deferred compensation and money I earned and invested. 😞
👍️0
10nisman 10nisman 24 hours ago
> SMH. Why would either a patient or injector make a video like that? Makes absolute zero sense. You want an injector to say... I'm an idiot and didn't know what I was doing, but now I do? Or you want a patient to say I went to a really bad injector but then found a new injector who knows what they are doing?
👍️ 3
iwfal iwfal 24 hours ago
Instagram - I’ve yet to see a *recent* Instagram of either a patient or injector who made reference to fact that initially they had problems, but decided to give it another try with a more experienced injector and it worked great.

Revance is going to need a lot more of this (above) kind of patient or injector.
🤡 1
go seek go seek 1 day ago
Daxxi review
https://www.instagram.com/reel/C5Piu2cMvqv/?igsh=MTUzZ3Y3bmZrcTVyaw==

https://www.instagram.com/reel/C38JIsaRd9C/?igsh=bmx1a3F4MnhnODYz
👍️0
wowster wowster 1 day ago
Do you see it turning around?
👍️0
mouton29 mouton29 2 days ago
You say,

Rather than having a lasting treatment, the condition treated starts to return in three months or less and you have to live with it for another three months or more.

Evidently you believe that redosing is not permitted for 6 months? Where is this coming from? It’s flat wrong.

From the package insert:

DAXXIFY should be administered no more frequently than every three months.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761127s000lbl.pdf

And later, we have:

In an 84-week open label repeat-dose safety study in glabellar lines, 2691 subjects were treated with 40 U of
DAXXIFY. Of these, 2380 subjects received one treatment with DAXXIFY, 882 received two treatments with
DAXXIFY and 568 subjects received three treatments with DAXXIFY. Adverse reactions were reported in 535
of the 2691 subjects (20%). The adverse reaction profile was similar to that reported in single dose trials.
Injection site reactions were the most common adverse reactions, reported in 9% of subjects [including injection
site pain (4%) , injection site erythema (3%), injection site oedema (3%), injection site bruising (1%), injection
site papule (
👍️ 7
vinmantoo vinmantoo 2 days ago
Therapeutic is everything.

Nonsense. Aesthetics AND therapeutics are everything
👍️ 2
alertmeipp alertmeipp 2 days ago
I agree they could sell it for $8 for sure but they won’t unless they have been lying to investors

Don’t think we have disagreements on this
👍️ 1
vinmantoo vinmantoo 2 days ago
We are not “savvy investors”, and a lot of us have never sold a single share of Revance stock. We are humans first, and employees with kids, babies on the way, student loan debt, mortgages, retirement plans. Our compensation packages were initially structured where Revance stock was big financial motivator to stay. We also believe(d) in the product but not in Dustin and Mark’s strategy, yes Mark was in on it. It was a strategy I quietly questioned.

Are you talking about stock grants that never became in the money? If so, I am sorry you didn't get a big windfall but you didn't lose money you invested. Most people don't get stock grants in companies where they are employed. I have never gotten a single share when I worked in companies, not that I am upset or unhappy about it. If I did get them I would consider them as a possible windfall not count on them as money. By the way, I think companies are way too extravagant in doling out stock options and stock grants to employees.

To date I have lost almost $400k in Revance stock, I imagine some of my colleagues with bigger titles or longer stints have lost a lot more, but that’s a life changing amount of money for me.

I am sorry you have lost money, just as I am sorry for anyone else who has invested in RVNC and lost money myself included, but it isn't wise to invest in a company in which you work. That was the lesson the ENRON collapse should have driven home. If you are talking about stock grants and incentives that you were awarded and not being in the money, then you really didn't lose money because you didn't invest your own cold hard cash into RVNC. Even so, I am sure it hurts so I feel sorry for you and your co-workers.

More difficult are comments here about my colleagues losing their jobs as “cutting the fat” or “losers in marketing” or worse “good riddance”, as if applauding the indescribable loss of livelihoods and many millions in employee stock grants and purchases that have disappeared overnight.

Always sorry to hear about people losing their jobs, but that happens in businesses that are struggling, and RVNC is certainly struggling as it pushes to increase Daxxify market share in aesthetics and begins to enter the therapeutic market. I don't take any pleasure in seeing peopIe lose their jobs. I hope you and your coworkers are able to make it through, if not at RVNC, then perhaps at another job where you feel less stress, less pain and less anger.
🤡 1
Aestheticexec Aestheticexec 2 days ago
RVNC is a tragic story - cash hemorrhaging launch strategy in aesthetics that good & experienced people knew wouldn’t work. Self dealing and massive ego trips. Daxi could be positioned as THE workhorse toxin for aesthetic practices, paired with a workhorse filler line. Instead… investors got “prestige.”

Therapeutic is everything.
👍️ 2 💩 4 🤡 1
vinmantoo vinmantoo 3 days ago
What?? Are you actually saying a person must try the products a company sells before having an opinion? Wow!! Does that apply only to RVNC or is it for every company?
👍️ 2
go seek go seek 3 days ago
Yes… without a doubt Daxxi is an exceptional product. Tested experts vouch for its effectiveness, the high quality results and patient satisfaction. Experience with Daxxi is growing… with that, demand for the product will grow. The Genie is out of the bottle.
👍️ 2
10nisman 10nisman 3 days ago
Thanks for the post.

More difficult are comments here about my colleagues losing their jobs as “cutting the fat” or “losers in marketing” or worse “good riddance”, as if applauding the indescribable loss of livelihoods and many millions in employee stock grants and purchases that have disappeared overnight.All RIF's and headcount reductions are difficult. Nobody wants to make them, and good people get caught-up in them (along with unneeded / low performing employees). Unfortunately today, most employees have never experienced a RIF and the emotions that come with it (anxiety, etc.). I've seen countless RIF's in my restructuring days, and all of them were needed to put the business in a position to survive and in a lot of cases thrive. With the onset of AI, all employees should be evaluating their actual value and how they are likely going to be impacted over the next 24+ months.

We are not “savvy investors”, and a lot of us have never sold a single share of Revance stock. We are humans first, and employees with kids, babies on the way, student loan debt, mortgages, retirement plans. Our compensation packages were initially structured where Revance stock was big financial motivator to stay. We also believe(d) in the product but not in Dustin and Mark’s strategy, yes Mark was in on it. It was a strategy I quietly questioned.The product is the same, and the share price is fixable. I don't know one great company that hasn't seen their share price cut in half at least once, nor hasn't implemented sizeable RIF's... Life is about what you do when you've been knocked on your butt. The good / great people use it as motivation to thrive --- bouncing back quickly, while others find it as a perfect excuse to complain and blame their life outcomes on others. Ball is in your court...

Working at Revance is as Emmanow said, “sad”. It’s also like walking barefoot on a tight rope laden with shards of glass. We don’t sleep at night with worry, by day it’s hard to focus on work.Like I said earlier, for those that have never been through a RIF or who aren't comfortable they are adding real value, often experience anxiety during times like this. The best employees step-up --- rolling up their sleeves and willing to take on even more responsibility. And although it's always easier said then done, you cannot control the things you cannot control. Worrying you may be next doesn't help anyone. Focus on what you can control and kick-ass everyday.
👍️ 1
10nisman 10nisman 3 days ago
Wonderful rule!!! If everybody were to follow it, including you, of course, there would only be one or two posts in the last few months.Ian --- I'll be happy to pay for your Daxxy, as you could really use some real-life experience before talking absolute non-sense. BTW, my real life experience is via my wife and sister who have had similar wonderful experiences as Dew.
👍️ 5 💯 3
alertmeipp alertmeipp 3 days ago
Sorry to hear, it’s unhealthy and somehow silly to continue to work for RVNC in your circumstances

Are you good at what you do?

If you are, just quit and move on. If not, maybe just accept the facts that sometimes somehow some even more incompetent people will become your leader.

Life is too short to be living so miserablely.

Not trying to be offensive here but sometimes, you have to learn to let go
👍️ 2 🤡 2
10nisman 10nisman 3 days ago
If they sold anywhere close to 8, that could only mean they have been lying about blockbuster potential of Daxxify all along. No one would sell a potential blockbuster drug for 1 billion EVRVNC isn't up for sale and nobody is lying about blockbuster potential. The question was whether RVNC could be sold today for $8 or more, and the answer is an obvious yes. Period.

This board needs to reduce the non-sense posting and restating the same comments over, and over, and over again. Either you believe in Daxxy and its potential or you don't. If you don't like Foley, sell and move on. Otherwise, accept the fact when you invest in RVNC you get Management. If you're long --- support the Company in whatever manner you can. If you're here solely to bash and don't have a position in RVNC, go do something productive in the world and if you cannot think of anything let me know.
👍️ 3
edcoolidge edcoolidge 3 days ago
I'm sorry you lost money on the stock and are concerned about your job security. I am in the camp that Foley is a disaster and should be exited. However, your claim about social media is wrong. The majority of social media posts shared here are not from Revance but actually from Revance's customers. Many people here have first-hand experience with Daxxify. To suggest that is all just marketing is completely disingenuous.
👍️ 1 🤡 1
Ms.Dtox Ms.Dtox 3 days ago
This is the most considerate post I’ve read here.

As a current Revance employee it’s been hard to read many statements here not based in reality, a truth that those of us who are living it daily know.

More difficult are comments here about my colleagues losing their jobs as “cutting the fat” or “losers in marketing” or worse “good riddance”, as if applauding the indescribable loss of livelihoods and many millions in employee stock grants and purchases that have disappeared overnight.

We are not “savvy investors”, and a lot of us have never sold a single share of Revance stock. We are humans first, and employees with kids, babies on the way, student loan debt, mortgages, retirement plans. Our compensation packages were initially structured where Revance stock was big financial motivator to stay. We also believe(d) in the product but not in Dustin and Mark’s strategy, yes Mark was in on it. It was a strategy I quietly questioned.

When stock began to fall employees were on long black out periods and could not sell, so we were offered revised comp packages with more stock incentives to keep us working tirelessly to support a marketing strategy most of us didn’t believe in.

Our executive leaders have been kept in the dark and axed too with no notice. Our CEO has yet to hold a town hall, nor has he sent a company-wide email of encouragement. There is a complete lack of transparency or compassion in the rest of the C-suite.

When this forum is encouraged by Revance social media posts and Erica posing in front of a Power to the Peptide wrapped car I shared they shouldn’t be, it’s straight up advertising. It’s not that I hate Revance and Daxxify or want it to fail, quite the opposite, my attempt here was to provide information that could curb false speculation. More to the point my posts were meant to say, if you are basing financial decisions on Revance social media posts, please don’t.

To date I have lost almost $400k in Revance stock, I imagine some of my colleagues with bigger titles or longer stints have lost a lot more, but that’s a life changing amount of money for me.

Working at Revance is as Emmanow said, “sad”. It’s also like walking barefoot on a tight rope laden with shards of glass. We don’t sleep at night with worry, by day it’s hard to focus on work. Any day now I’ll get an HR meeting added to my calendar late at night and at 8 am I’ll log on from home for a 2 minute conversation to inform me I’m another Revance casualty with a 2 month severance. At the end of that call my laptop will instantly lock and the Revance waking nightmare I’ve been living will end.

Thank you Emmanow for showing some real compassion here. 🙂
👍️ 2
alertmeipp alertmeipp 3 days ago
If they sold anywhere close to 8, that could only mean they have been lying about blockbuster potential of Daxxify all along.

No one would sell a potential blockbuster drug for 1 billion EV

I do wish they would establish a commercial partnership, let a larger corporation spent tons of sales and marketing, and RVNC just collect royalties.
👍️ 1
alertmeipp alertmeipp 3 days ago
The same WS you mentioned paid close to 40 bucks to buy RVNC not long ago, the same WS were buying up GME and AMC into unbelievable valuations.

I bet not many in the actual wall street knows about RVNC, its a small cap for them, most of them can’t even build a decent size position without move up or down the stock substantially.

The job cut is sad but that’s probably better for everybody in the long run.
👍️ 2
Emannow Emannow 3 days ago
Spoke to a few people who still have jobs at RVNC Headquarters and they said it is a sad place since so many people have lost their jobs. I believe Dew's statement that Foley will eventually bring RVNC into profitability and sell the company. The sad part is Foley's bad decisions are the reason so many have lost their jobs. Foley should be ashamed of how his bad decisions negatively affected so many lives. Maybe Evolus will publish a pre release of their sales prior to Allergan's sales at the end of this month. I would expect RVNC sales to be similar to Evolus.

Per Q1 Daxi sales, I have heard several reps hit their Daxi quota ahead of their RHA quota...so Daxi is gaining traction and sales are growing. I believe Foley has a good idea on what CD sales will be and has factored these numbers into his current expenses to create a balanced spending budget for the next few quarters. RVNC will never go bankrupt since there are a hand full of companies who would buy RVNC today. Once the Allergan lawsuit is closed at the end of 2024, you will start to see buyout offers. Remember, Allergan sues everyone....There are always lawsuits happening between Allergan and their employees over miss use of the cash pay products...Allergan settles these out of court because Allergan does not want the legal system or FDA to have documented evidence of their doings. .Allergan has very dirty hands.

The sad reality is that the Wall Street computers are continuing to drive the SP down. At some point the SP will bottom which i think will be soon, Foley has to start communicating with Wall Street so investors believe in RVNC.
👍️ 6
vinmantoo vinmantoo 3 days ago
A patient with a bad experience and the inadequately diligent injector are both more likely to blame the drug. This isn’t entirely unfair - given that Revance did a lousy rollout in this regard. But note that at some point a tipping point will be reached - they’ll hear from their friend at a good Daxxy injector. Then they will either switch injectors or force their current injector to come up to speed. But this may not be a quick process, and in the meantime Revance is bleeding $.

Exactly. That is the race RVNC investors hope to win, revenue increases vs cash burn.
👍️ 1
vinmantoo vinmantoo 3 days ago
I doubt anyone, male or female, would be drawn to Daxxify as long as it works for two or three months and then makes you look as if you are ageing rapidly for the next three or four months.

What in the world are you talking about? Why are you lying?

It has been broadcast and advertised as doing wonders for six months? With that misleading BS, I doubt that it can ever be successful.

Your comment is misleading BS.
👍️ 1
edcoolidge edcoolidge 3 days ago
Those are mostly old now. Would hate to see RVNCQ tag your post with a clown emoji.

So, here's some recent ones, although these results must all be fake because I heard from CosmeticMD that Daxxify "doesn't work."

https://www.instagram.com/p/C5oQLI5yXl8/?igsh=MTduMW40bGZjbDJvZg==
https://www.instagram.com/p/C5ogTVxxGO-/?igsh=MXNudWo1Ymc0b2djMA==
https://www.instagram.com/p/C5nz-JiuvU3/?igsh=ano1cnlzb3dlNTZh
https://www.instagram.com/p/C5g4SKdxt-q/?igsh=MTRrbHR5aHR1ZXVwcg==
https://www.instagram.com/p/C5OUsswRhuQ/?igsh=NTljaW5yYnp0cWds
https://www.instagram.com/p/C48GCY9JfzA/?igsh=azZ3a3o0djRuZWZo
https://www.instagram.com/p/C44H71vx9tA/?igsh=MW43aWhnMmo1ZWIxag==
👍️ 2 🤡 1
go seek go seek 3 days ago
Why I’m not concerned about daxxify’s potential in the marketplace…

https://www.instagram.com/reel/C4J8jhcuIdq/?igsh=M3R2dmNrb2Vnazlx

https://www.instagram.com/reel/CiaBtY-POUg/?igsh=bzk3MXViemxqa2Vy

https://www.instagram.com/reel/C2id52jJlcG/?igsh=eXIyMDJpOXNncDh6

https://www.instagram.com/reel/CooGVafrqe_/?igsh=d2F0cDBmNXF2amVz

https://www.instagram.com/reel/CobKg6pMVWM/?igsh=NWRubTRpYzV4OHUw

Daxxify… What have we learned?
https://www.instagram.com/reel/CthjfONu9pb/?igsh=MWE3dndzbjMxcTB1bA==
👍️0
alertmeipp alertmeipp 3 days ago
Be Patient. My friends. If you know, you know.
👍️ 2
iwfal iwfal 3 days ago
Is there any way for a patient to determine whether or not her injector was untrained, improperly trained, or inadequately trained?

The best way is to determine what percentage of their practice is Daxxy, and for how long. If they get poor results and never spend the time (and patient patience) to figure it out… then they’ll likely largely stop using it.

In my opinion, it’s more likely that she will blame the result on Daxxify. … loudly and vociferously to many others.

Of course this is true. A patient with a bad experience and the inadequately diligent injector are both more likely to blame the drug. This isn’t entirely unfair - given that Revance did a lousy rollout in this regard. But note that at some point a tipping point will be reached - they’ll hear from their friend at a good Daxxy injector. Then they will either switch injectors or force their current injector to come up to speed. But this may not be a quick process, and in the meantime Revance is bleeding $.
👍️ 6
edcoolidge edcoolidge 3 days ago
In my opinion, it’s more likely that she will blame the result on Daxxify. … loudly and vociferously to many others.
Until she sees her friends and people on social media glowing about their Daxxify results and realizes she's been duped by a crooked or crappy CosmeticMD.
👍️ 1
IanFromSI IanFromSI 3 days ago
Is there any way for a patient to determine whether or not her injector was untrained, improperly trained, or inadequately trained?

In my opinion, it’s more likely that she will blame the result on Daxxify. … loudly and vociferously to many others.

Unless, and until, RVNC corrects the training problem, selling Daxxify will be an uphill battle

👍️ 2
edcoolidge edcoolidge 3 days ago
I suspect between likely no rate cuts this year, a difficult balance sheet, a week Q1, and distrust of Foley, we will see RVNC in the $2's this year. Revance is priced for likely bankruptcy. They're hardly alone. Nobody wants to own unprofitable small caps with debt in this environment. Many of these companies will go bankrupt. If Revance doesn't then we will likely look back on the current share price as an excellent opportunity. The RVNCQ clowns on this board want to convince everyone that the share price collapse is proof Daxxify "doesn't work" or is inferior to other toxins. That's wrong.
👍️ 2 🤡 1

Your Recent History

Delayed Upgrade Clock